TW200534982A - Molds for producing contact lenses - Google Patents
Molds for producing contact lenses Download PDFInfo
- Publication number
- TW200534982A TW200534982A TW93110305A TW93110305A TW200534982A TW 200534982 A TW200534982 A TW 200534982A TW 93110305 A TW93110305 A TW 93110305A TW 93110305 A TW93110305 A TW 93110305A TW 200534982 A TW200534982 A TW 200534982A
- Authority
- TW
- Taiwan
- Prior art keywords
- group
- patent application
- scope
- item
- alicyclic
- Prior art date
Links
- 238000000034 method Methods 0.000 claims abstract description 61
- 229920001577 copolymer Polymers 0.000 claims abstract description 60
- 238000004519 manufacturing process Methods 0.000 claims abstract description 15
- -1 functional element Chemical group 0.000 claims description 67
- 238000000465 moulding Methods 0.000 claims description 60
- 125000002723 alicyclic group Chemical group 0.000 claims description 47
- 239000000178 monomer Substances 0.000 claims description 42
- 239000000203 mixture Substances 0.000 claims description 32
- 238000000576 coating method Methods 0.000 claims description 31
- 239000011248 coating agent Substances 0.000 claims description 30
- 239000004743 Polypropylene Substances 0.000 claims description 29
- 125000003368 amide group Chemical group 0.000 claims description 27
- 239000008199 coating composition Substances 0.000 claims description 27
- 229920001155 polypropylene Polymers 0.000 claims description 27
- 125000000217 alkyl group Chemical group 0.000 claims description 24
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 23
- 239000000463 material Substances 0.000 claims description 20
- 229920000642 polymer Polymers 0.000 claims description 18
- 239000000126 substance Substances 0.000 claims description 17
- 239000000654 additive Substances 0.000 claims description 16
- 230000009477 glass transition Effects 0.000 claims description 16
- 230000005484 gravity Effects 0.000 claims description 16
- 125000003545 alkoxy group Chemical group 0.000 claims description 15
- 230000002079 cooperative effect Effects 0.000 claims description 15
- 125000001424 substituent group Chemical group 0.000 claims description 15
- 238000009472 formulation Methods 0.000 claims description 14
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 14
- 229910052736 halogen Inorganic materials 0.000 claims description 13
- 150000002367 halogens Chemical class 0.000 claims description 13
- 239000000155 melt Substances 0.000 claims description 12
- 229920002125 Sokalan® Polymers 0.000 claims description 11
- 239000000017 hydrogel Substances 0.000 claims description 11
- 239000001257 hydrogen Substances 0.000 claims description 11
- 229910052739 hydrogen Inorganic materials 0.000 claims description 11
- 125000002837 carbocyclic group Chemical group 0.000 claims description 9
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 8
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 8
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 7
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 6
- 150000001412 amines Chemical class 0.000 claims description 6
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 claims description 6
- 239000001301 oxygen Substances 0.000 claims description 6
- 229910052760 oxygen Inorganic materials 0.000 claims description 6
- 229920003023 plastic Polymers 0.000 claims description 6
- 239000004033 plastic Substances 0.000 claims description 6
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 claims description 6
- 230000000845 anti-microbial effect Effects 0.000 claims description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 4
- UURVHRGPGCBHIC-UHFFFAOYSA-N 3-(ethenoxycarbonylamino)propanoic acid 4-[[[[[[[[[[[[[[[[[[[[[[[[[[[4-ethenoxycarbonyloxybutyl(dimethyl)silyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]oxy-dimethylsilyl]butyl ethenyl carbonate 1-ethenylpyrrolidin-2-one ethenyl N-[3-tris(trimethylsilyloxy)silylpropyl]carbamate Chemical compound C=CN1CCCC1=O.OC(=O)CCNC(=O)OC=C.C[Si](C)(C)O[Si](CCCNC(=O)OC=C)(O[Si](C)(C)C)O[Si](C)(C)C.C[Si](C)(CCCCOC(=O)OC=C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)CCCCOC(=O)OC=C UURVHRGPGCBHIC-UHFFFAOYSA-N 0.000 claims description 4
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 claims description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 4
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 claims description 4
- 125000003118 aryl group Chemical group 0.000 claims description 4
- 229910000077 silane Inorganic materials 0.000 claims description 4
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 claims description 4
- ZOPSJJCUEOEROC-NSQCPRBHSA-N 3-[[butyl(dimethyl)silyl]oxy-dimethylsilyl]propyl 2-methylprop-2-enoate;n,n-dimethylprop-2-enamide;1-ethenylpyrrolidin-2-one;2-hydroxyethyl 2-methylprop-2-enoate;[(2r)-2-hydroxy-3-[3-[methyl-bis(trimethylsilyloxy)silyl]propoxy]propyl] 2-methylprop-2-enoat Chemical compound CN(C)C(=O)C=C.C=CN1CCCC1=O.CC(=C)C(=O)OCCO.CC(=C)C(=O)OCCOC(=O)C(C)=C.CCCC[Si](C)(C)O[Si](C)(C)CCCOC(=O)C(C)=C.CC(=C)C(=O)OC[C@H](O)COCCC[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C ZOPSJJCUEOEROC-NSQCPRBHSA-N 0.000 claims description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 3
- 229920001400 block copolymer Polymers 0.000 claims description 3
- 239000001913 cellulose Substances 0.000 claims description 3
- 229920002678 cellulose Polymers 0.000 claims description 3
- 125000004122 cyclic group Chemical group 0.000 claims description 3
- SFYLVTNFLRJWTA-UHFFFAOYSA-N fluoren-1-imine Chemical compound C1=CC=C2C3=CC=CC(=N)C3=CC2=C1 SFYLVTNFLRJWTA-UHFFFAOYSA-N 0.000 claims description 3
- 150000004676 glycans Chemical class 0.000 claims description 3
- 125000005843 halogen group Chemical group 0.000 claims description 3
- 125000001841 imino group Chemical group [H]N=* 0.000 claims description 3
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 3
- 229920000172 poly(styrenesulfonic acid) Polymers 0.000 claims description 3
- 229920002401 polyacrylamide Polymers 0.000 claims description 3
- 239000004626 polylactic acid Substances 0.000 claims description 3
- 229920001444 polymaleic acid Polymers 0.000 claims description 3
- 239000005017 polysaccharide Substances 0.000 claims description 3
- 229920001282 polysaccharide Polymers 0.000 claims description 3
- 229940005642 polystyrene sulfonic acid Drugs 0.000 claims description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 3
- 229920005604 random copolymer Polymers 0.000 claims description 3
- NLAIHECABDOZBR-UHFFFAOYSA-M sodium 2,2-bis(2-methylprop-2-enoyloxymethyl)butyl 2-methylprop-2-enoate 2-hydroxyethyl 2-methylprop-2-enoate 2-methylprop-2-enoate Chemical compound [Na+].CC(=C)C([O-])=O.CC(=C)C(=O)OCCO.CCC(COC(=O)C(C)=C)(COC(=O)C(C)=C)COC(=O)C(C)=C NLAIHECABDOZBR-UHFFFAOYSA-M 0.000 claims description 3
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 claims description 2
- PMPVIKIVABFJJI-UHFFFAOYSA-N Cyclobutane Chemical compound C1CCC1 PMPVIKIVABFJJI-UHFFFAOYSA-N 0.000 claims description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 2
- 229920002845 Poly(methacrylic acid) Polymers 0.000 claims description 2
- 229920001616 Polymacon Polymers 0.000 claims description 2
- 150000003519 bicyclobutyls Chemical class 0.000 claims description 2
- ARUKYTASOALXFG-UHFFFAOYSA-N cycloheptylcycloheptane Chemical compound C1CCCCCC1C1CCCCCC1 ARUKYTASOALXFG-UHFFFAOYSA-N 0.000 claims description 2
- WVIIMZNLDWSIRH-UHFFFAOYSA-N cyclohexylcyclohexane Chemical compound C1CCCCC1C1CCCCC1 WVIIMZNLDWSIRH-UHFFFAOYSA-N 0.000 claims description 2
- 239000004914 cyclooctane Substances 0.000 claims description 2
- NLUNLVTVUDIHFE-UHFFFAOYSA-N cyclooctylcyclooctane Chemical compound C1CCCCCCC1C1CCCCCCC1 NLUNLVTVUDIHFE-UHFFFAOYSA-N 0.000 claims description 2
- 230000000694 effects Effects 0.000 claims description 2
- 229940075507 glyceryl monostearate Drugs 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 claims description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 claims description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 claims description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 claims description 2
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 claims 12
- 150000002431 hydrogen Chemical class 0.000 claims 7
- 230000000996 additive effect Effects 0.000 claims 6
- 239000012620 biological material Substances 0.000 claims 6
- 150000001335 aliphatic alkanes Chemical class 0.000 claims 3
- 125000003277 amino group Chemical group 0.000 claims 3
- 241000159846 Centrosema pascuorum Species 0.000 claims 2
- 241000219122 Cucurbita Species 0.000 claims 2
- 235000009852 Cucurbita pepo Nutrition 0.000 claims 2
- 229920000954 Polyglycolide Polymers 0.000 claims 2
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 claims 2
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims 2
- 125000003739 carbamimidoyl group Chemical group C(N)(=N)* 0.000 claims 2
- SILSDTWXNBZOGF-KUZBFYBWSA-N chembl111058 Chemical compound CCSC(C)CC1CC(O)=C(\C(CC)=N\OC\C=C\Cl)C(=O)C1 SILSDTWXNBZOGF-KUZBFYBWSA-N 0.000 claims 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 2
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 claims 2
- 239000004633 polyglycolic acid Substances 0.000 claims 2
- 229920006395 saturated elastomer Polymers 0.000 claims 2
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 claims 2
- 235000021286 stilbenes Nutrition 0.000 claims 2
- QRIMLDXJAPZHJE-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(O)CO QRIMLDXJAPZHJE-UHFFFAOYSA-N 0.000 claims 1
- OWPUOLBODXJOKH-UHFFFAOYSA-N 2,3-dihydroxypropyl prop-2-enoate Chemical compound OCC(O)COC(=O)C=C OWPUOLBODXJOKH-UHFFFAOYSA-N 0.000 claims 1
- CYSPWCARDHRYJX-UHFFFAOYSA-N 9h-fluoren-1-amine Chemical compound C12=CC=CC=C2CC2=C1C=CC=C2N CYSPWCARDHRYJX-UHFFFAOYSA-N 0.000 claims 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims 1
- 125000001317 arsoryl group Chemical group *[As](*)(*)=O 0.000 claims 1
- 239000011230 binding agent Substances 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 239000003610 charcoal Substances 0.000 claims 1
- 229910052802 copper Inorganic materials 0.000 claims 1
- 239000010949 copper Substances 0.000 claims 1
- WJTCGQSWYFHTAC-UHFFFAOYSA-N cyclooctane Chemical compound C1CCCCCCC1 WJTCGQSWYFHTAC-UHFFFAOYSA-N 0.000 claims 1
- 210000004268 dentin Anatomy 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 239000005357 flat glass Substances 0.000 claims 1
- 125000000524 functional group Chemical group 0.000 claims 1
- 125000000879 imine group Chemical group 0.000 claims 1
- 239000012535 impurity Substances 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 238000001459 lithography Methods 0.000 claims 1
- JDTXSWGCYBOHDZ-UHFFFAOYSA-N n-(9h-fluoren-1-yl)prop-2-enamide Chemical compound C1C2=CC=CC=C2C2=C1C(NC(=O)C=C)=CC=C2 JDTXSWGCYBOHDZ-UHFFFAOYSA-N 0.000 claims 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
- 125000004043 oxo group Chemical group O=* 0.000 claims 1
- 239000002689 soil Substances 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims 1
- 230000007704 transition Effects 0.000 claims 1
- 238000002360 preparation method Methods 0.000 description 9
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 8
- 102100026735 Coagulation factor VIII Human genes 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 238000004528 spin coating Methods 0.000 description 7
- 230000007547 defect Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
- 239000004698 Polyethylene Substances 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000003085 diluting agent Substances 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 229920000573 polyethylene Polymers 0.000 description 5
- 229920001296 polysiloxane Polymers 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 239000002981 blocking agent Substances 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 4
- 238000001746 injection moulding Methods 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 239000012778 molding material Substances 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 4
- 238000005507 spraying Methods 0.000 description 4
- HWSSEYVMGDIFMH-UHFFFAOYSA-N 2-[2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOCCOC(=O)C(C)=C HWSSEYVMGDIFMH-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 125000000304 alkynyl group Chemical group 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000012937 correction Methods 0.000 description 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 238000007639 printing Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- RIWRBSMFKVOJMN-UHFFFAOYSA-N 2-methyl-1-phenylpropan-2-ol Chemical compound CC(C)(O)CC1=CC=CC=C1 RIWRBSMFKVOJMN-UHFFFAOYSA-N 0.000 description 2
- PRNCMAKCNVRZFX-UHFFFAOYSA-N 3,7-dimethyloctan-1-ol Chemical compound CC(C)CCCC(C)CCO PRNCMAKCNVRZFX-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229940116333 ethyl lactate Drugs 0.000 description 2
- 238000005227 gel permeation chromatography Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000003754 machining Methods 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- FATBGEAMYMYZAF-KTKRTIGZSA-N oleamide Chemical compound CCCCCCCC\C=C/CCCCCCCC(N)=O FATBGEAMYMYZAF-KTKRTIGZSA-N 0.000 description 2
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 229920000098 polyolefin Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 230000003746 surface roughness Effects 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- 239000012956 1-hydroxycyclohexylphenyl-ketone Substances 0.000 description 1
- HECLRDQVFMWTQS-RGOKHQFPSA-N 1755-01-7 Chemical compound C1[C@H]2[C@@H]3CC=C[C@@H]3[C@@H]1C=C2 HECLRDQVFMWTQS-RGOKHQFPSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- CFGGNXFNDNQZKD-UHFFFAOYSA-N 2-(9H-fluoren-1-yl)prop-2-enoic acid Chemical compound C1C2=CC=CC=C2C2=C1C(C(=C)C(=O)O)=CC=C2 CFGGNXFNDNQZKD-UHFFFAOYSA-N 0.000 description 1
- YDOVPVLKADMTFE-UHFFFAOYSA-N 2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethanol;prop-2-enoic acid Chemical compound OC(=O)C=C.OCCOCCOCCOCCO YDOVPVLKADMTFE-UHFFFAOYSA-N 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- IBHHTADZYDLHPM-UHFFFAOYSA-N 2-methylnonan-4-ol Chemical compound CCCCCC(O)CC(C)C IBHHTADZYDLHPM-UHFFFAOYSA-N 0.000 description 1
- HNNZBZKURNBXOO-UHFFFAOYSA-N 3-(methylamino)butan-1-ol Chemical compound CNC(C)CCO HNNZBZKURNBXOO-UHFFFAOYSA-N 0.000 description 1
- 241000238876 Acari Species 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 229920013665 Ampacet Polymers 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 229920001634 Copolyester Polymers 0.000 description 1
- UAUDZVJPLUQNMU-UHFFFAOYSA-N Erucasaeureamid Natural products CCCCCCCCC=CCCCCCCCCCCCC(N)=O UAUDZVJPLUQNMU-UHFFFAOYSA-N 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920000388 Polyphosphate Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 1
- 108050006002 RNA polymerase sigma factor FliA Proteins 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229920002359 Tetronic® Polymers 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- SMEGJBVQLJJKKX-HOTMZDKISA-N [(2R,3S,4S,5R,6R)-5-acetyloxy-3,4,6-trihydroxyoxan-2-yl]methyl acetate Chemical compound CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O)OC(=O)C)O)O SMEGJBVQLJJKKX-HOTMZDKISA-N 0.000 description 1
- OCKWAZCWKSMKNC-UHFFFAOYSA-N [3-octadecanoyloxy-2,2-bis(octadecanoyloxymethyl)propyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC OCKWAZCWKSMKNC-UHFFFAOYSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000000181 anti-adherent effect Effects 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- MQDJYUACMFCOFT-UHFFFAOYSA-N bis[2-(1-hydroxycyclohexyl)phenyl]methanone Chemical compound C=1C=CC=C(C(=O)C=2C(=CC=CC=2)C2(O)CCCCC2)C=1C1(O)CCCCC1 MQDJYUACMFCOFT-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229920006026 co-polymeric resin Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000000748 compression moulding Methods 0.000 description 1
- 150000001923 cyclic compounds Chemical class 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 238000007516 diamond turning Methods 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- DGVMNQYBHPSIJS-UHFFFAOYSA-N dimagnesium;2,2,6,6-tetraoxido-1,3,5,7-tetraoxa-2,4,6-trisilaspiro[3.3]heptane;hydrate Chemical compound O.[Mg+2].[Mg+2].O1[Si]([O-])([O-])O[Si]21O[Si]([O-])([O-])O2 DGVMNQYBHPSIJS-UHFFFAOYSA-N 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- UAUDZVJPLUQNMU-KTKRTIGZSA-N erucamide Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(N)=O UAUDZVJPLUQNMU-KTKRTIGZSA-N 0.000 description 1
- FAJXAMXYQAQDJU-UHFFFAOYSA-N ethyl acetate;2-methylprop-2-enoic acid Chemical compound CCOC(C)=O.CC(=C)C(O)=O FAJXAMXYQAQDJU-UHFFFAOYSA-N 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- PHTQWCKDNZKARW-UHFFFAOYSA-N isopentyl alcohol Natural products CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 1
- 238000003698 laser cutting Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- MBHINSULENHCMF-UHFFFAOYSA-N n,n-dimethylpropanamide Chemical compound CCC(=O)N(C)C MBHINSULENHCMF-UHFFFAOYSA-N 0.000 description 1
- CRSOQBOWXPBRES-UHFFFAOYSA-N neopentane Chemical compound CC(C)(C)C CRSOQBOWXPBRES-UHFFFAOYSA-N 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- FATBGEAMYMYZAF-UHFFFAOYSA-N oleicacidamide-heptaglycolether Natural products CCCCCCCCC=CCCCCCCCC(N)=O FATBGEAMYMYZAF-UHFFFAOYSA-N 0.000 description 1
- WKGDNXBDNLZSKC-UHFFFAOYSA-N oxido(phenyl)phosphanium Chemical compound O=[PH2]c1ccccc1 WKGDNXBDNLZSKC-UHFFFAOYSA-N 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 125000004817 pentamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920000191 poly(N-vinyl pyrrolidone) Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001483 poly(ethyl methacrylate) polymer Polymers 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000001205 polyphosphate Substances 0.000 description 1
- 235000011176 polyphosphates Nutrition 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 238000007142 ring opening reaction Methods 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000002888 zwitterionic surfactant Substances 0.000 description 1
Landscapes
- Eyeglasses (AREA)
Abstract
Description
200534982 A7200534982 A7
‘㈣料造隱料鏡有狀《物與其使 用方法。 相關之申請案件 5 申月案件為美國專利申請序號10/395,755之部份延 續’後者為美國專利申請序號職2,373之部份延續。 ^ 發明背景 眼鏡自195G年代以來即已被商業地用於改良視 1〇 f,隱形眼鏡起初以硬質材料製造,雖然這些隱形眼鏡目 月J仍被使用’但由於其初戴時之舒適度較差,與其_氧之 /乡透|±相對車乂低,故不適合所有的病人。此領域爾舉發展 出以水凝膠為基質之軟質隱形眼鏡,時下倍受歡迎,這些 鏡=具有較高的氧滲透性,而且戴用時常較製自硬質材料 15 之隱形眼鏡舒適。不同於硬質鏡片製自將轉硬片車床加 經濟部智慧財產局員工消費合作社印製 工,具延展錄質輯之製造,常藉賴二部件模塑物以 生成鏡片,其各個半部件具有與所欲完工鏡片相符之圖 形,這些製模塑物與其製法之實例可參見··美國專利‘It ’s like making objects with hidden lenses. Objects and how to use them. Relevant Application Cases 5 The monthly application case is a partial continuation of US patent application serial number 10 / 395,755 'and the latter is a partial continuation of US patent application serial number 2,373. ^ BACKGROUND OF THE INVENTION Eyeglasses have been used commercially to improve vision 10f since the 195Gs. Contact lenses were originally made of hard materials. Although these contact lenses are still used 'J, but because of their poor comfort when first worn Compared with _ Oxygen / Hometown | ±, the relative car weight is low, so it is not suitable for all patients. In this field, we have developed soft contact lenses based on hydrogels, which are now very popular. These lenses have high oxygen permeability and are more comfortable to wear than contact lenses made of hard materials. Different from the production of hard lens lathes and hard-coated lathes plus the printing staff of the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs, which has extended quality records, it often relies on two-component moldings to produce lenses. The pattern of the desired completed lens, these examples of moldings and methods can be found in the US patent
4,565,348、4,640,489、4,495,313、JP 08025378、與 JP 20 0726644,故將其全文併入本文供參考。 這些二部件模塑物包含一公成員,其凸的表面對應於 7G工叙片之背面曲線,與一母成員,其凹的表面對應於完 工鏡片之正面曲線,使用這些模塑物製備鏡片時,將未熟 化之鏡片配方置於模塑物半部件之凹與凸的表面間,而後 五、發明說明(2) 進行熟化。隨後將熟化鏡片與模塑物使用一種液體介質加 以處理,而使熟化鏡片自模塑物表面釋出。雖然此為一種 簡易的方法,但需符合數個要求方可製得可使用之鏡片: 第一,模塑物製自之材料必須具有與未熟化鏡片配方化學 5 地相容之性能,第二,模塑物之材料必須能夠承受熟化條 件,並可與這些條件相容,例如:鏡片可藉熱與/或光熟 化。若鏡片之熟化係將光傳輸至未熟化聚合物,重要的是 鏡片模塑物允許傳輸適當波長之光,第三,模塑材料必須 不與熟化鏡片相黏至妨礙熟化鏡片釋出之程度。通常鏡片 10 之製備係於一製造環境下,重要的是鏡片能夠可移除地黏 附於該同一鏡片模塑物,而且進行分離時於可重覆g可預 知之方式,因此選擇製作模塑物的適當材料,一直奏製造 軟質隱形眼鏡者所關心的題材。 其他已被用於製備二部件鏡片模塑物之材料,如··聚 [5 丙烯、聚笨乙烯、聚乙烯、聚甲基丙烯酸甲酯、及於主鏈 中包含一種脂環狀成份之經改質聚烯烴。雖然這些材料對 於發現不同的鏡片配方,特別是矽氧烷水凝膠鏡片配方, 十分有用,但仍需要其他有用的模塑物材料。 此外,此領域之新發展引導製自水凝膠與矽氧烷水凝 0 膠之隱形眼鏡,使用聚合物予以塗覆,藉以改良鏡片舒適 度,鏡片之塗覆常藉使用聚合物將熟化鏡片進行處理。近 來,聚合物塗覆鏡片之製造,係將二部件模塑物表面以一 種聚合物塗覆,添加一種未熟化的配方至經塗覆之鏡片模 塑物,再將鏡片熟化,而後將熟化之鏡片自模塑物釋出, A7 B7 200534982 五、發明說明(3) 而該熟化鏡片表面塗覆之聚合物為起始時附著於模塑物寺 面者,此方法更詳盡地敘述於2〇01 * 8月8日' 國專利申請案號_21,192,其名稱為” 改正物件之方法”,故將其全文併入本文供參考。當使用 此方法塗覆鏡片時,模塑物材料之選擇,甚至較製造未塗 覆之鏡片者更為嚴厲。 i 因此,對於製造鏡片模塑物,其可用於製造許多不同 類型之軟㈣練鏡者,健有未達叙需求,下列發明 即在滿足此需求。 10 15 經濟部智慧財產局員工消費合作社印製 20 發明詳沭 本發明包括一種用於製作鏡片之模塑物,其包括:主 要包含或包含-種脂·共聚物,其中該脂雜共^物包 括:主要包含或包含至少二個具有不同化學結構之脂環狀 單體。本說明書中所使用之,,鏡片,,一詞,係指任何置入眼 内或於眼上之眼睛裝置’這些裝置可提供光學橋正或做為 化妝之用。鏡片-詞包括但未受限於:軟質隱形眼鏡、眼 内鏡片、覆蓋鏡片、眼睛嵌人物、與光學嵌人物。已發明 之較佳鏡Μ為製自魏辟性體或水凝狀㈣隱形眼 鏡,其包括但未受,沒魏水轉與氟水凝膠。軟質 fe形眼鏡之配方揭示於:美國專利5,71〇,3〇2、w〇 9421698、EP 4G6161、〗p 2G()()()169()5、美國專利 5,998,498、美國專利申請序號〇9/957,299,於2觀年9 月20曰申睛、美國專利申請案號〇9/532,943、美國專利 -5- 200534982 A7 B7 五、發明說明(4 ) 10 15 經濟部智慧財產局員工消費合作社印製 20 6,087,4丨5、美國專利5,760,100、美國專利5,776,999、美 國專利5,789,461、美國專利5,849,811、與美國專利 5,965,631。其他可用於生成軟質隱形眼鏡之聚合物揭示於:美國專利6,419,858、6,308,314與6,416,690,故將前述參 考文獻之全文併入本文供參考。發明中特佳之鏡片 為:etafilcon A、genfilcon A、lenefilcon A、polymacon、 acquafilcon A、balafilcon A、lotrafilcon A、galyfilcon A、 senofilcon A。矽氧烷水凝膠之製備如於··美國專利5,998,498、美國專利中請案號09/532,943,為於2000年8 月30曰所申請美國專利申請案號09/532,943之部份延 續、美國專利序號〇9/957,299,於2001年9月20:日申 请。軟質隱形眼鏡之製備,如於:美國專利申請案號 60/318,536,名稱為”包含内部潤濕劑之生醫裝置”,於 2001年9月1〇日申請、與其具有相同名稱之非臨時性補 充物’於2002年9月6日申請、美國專利6,〇87,415、美 國專利5,760,1〇〇、美國專利5,776,999、美國專利 5,789,461 '美國專利5,849,8n、與美國專利5,965,63卜故將這些專利(與申請案件)以及所有其他揭示於本申請案 件之專利之全文,併入本文供參考。 本說明書中所使用之,,脂環狀單體,,一詞,係指其中至 少具有一個飽和碳環之可聚合化合物,飽和碳環可被一個 或多個下列群組之成員所取代’包括:氫、CM0烧基、鹵 素、錄、CM0烧氧基叛基、C|-l0烧氧基、氛基、酿胺 基、醯亞胺基、矽烷基、與選擇地CI1G烷基,其取代 訂 線 -6- A7 B7 2Θ0534982 五、發明說明( 係選自一個或多個下列群組之成員,包括··鹵素、經基、 cM〇烧氣基幾基、cMG烧氧基、氰基、醯胺基、酿亞胺 基、與碎燒基。脂環狀單體之實例包括,但未受其侷限: 可聚合之環丁烷、環戊烷'環己烷、環庚烷、環辛烷、雙 環丁烷、雙環戊烷、雙環己烷、雙環庚烷、雙環辛烷、與 原冰片炫。難者祕至少二個輯狀單體,經開環置換 合’而後進行氫化反應。由於共聚物十分昂貴,故 10 次替代單次為難,對㈣^以典型地使用數 時,其可使用超過—次。本發明較佳模塑物製備鏡片 包含飽和碳環之脂 未受其侷限於下列之結構·肢,其特佳之實例包括,但 154,565,348, 4,640,489, 4,495,313, JP 08025378, and JP 20 0726644, the entire contents of which are incorporated herein by reference. These two-part moldings include a male member whose convex surface corresponds to the back curve of the 7G industrial film, and a female member whose concave surface corresponds to the front curve of the finished lens. When using these moldings to prepare lenses , Put the uncured lens formula between the concave and convex surfaces of the half-mold of the molding, and then the description of the invention (2) for curing. The cured lens and molding are then treated with a liquid medium to release the cured lens from the surface of the molding. Although this is a simple method, there are several requirements that must be met before a usable lens can be made: first, the material from which the molding is made must be chemically compatible with the uncured lens formula, and second, The material of the molding must be able to withstand the curing conditions and be compatible with these conditions, for example, the lens can be cured by heat and / or light. If the curing of the lens transmits light to the uncured polymer, it is important that the lens molding allows transmission of light of an appropriate wavelength. Third, the molding material must not stick to the cured lens to the extent that it prevents the release of the cured lens. Usually lens 10 is prepared in a manufacturing environment. The important thing is that the lens can be removably adhered to the same lens molding, and the separation can be repeated in a predictable manner during separation. The appropriate materials have always been the subject of concern for those who make soft contact lenses. Other materials that have been used to make two-part lens moldings, such as poly [5 propylene, polyethylene, polyethylene, polymethyl methacrylate, and a process that contains an alicyclic component in the main chain Modified polyolefin. Although these materials are useful for discovering different lens formulations, especially silicone hydrogel lens formulations, other useful molding materials are still needed. In addition, new developments in this field have led to contact lenses made from hydrogels and silicone hydrogels coated with polymers to improve lens comfort. Lens coatings often use polymers to mature lenses. For processing. Recently, the manufacture of polymer-coated lenses involves coating the surface of a two-part molded article with a polymer, adding an uncured formulation to the coated lens molding, curing the lens, and then curing the lens. The lens is released from the molded product, A7 B7 200534982 V. Description of the invention (3) The polymer coated on the surface of the cured lens is initially attached to the mold surface. This method is described in more detail in 2. 01 * August 8 'National Patent Application No. _21,192, whose name is "Method of Correcting Objects", so the entire text is incorporated herein for reference. When using this method to coat lenses, the choice of molding material is even more severe than for those who manufacture uncoated lenses. i Therefore, for the manufacture of lens moldings, which can be used to make many different types of soft lenses, there is still a lack of demand, and the following inventions meet this demand. 10 15 Printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs 20 Detailed description of the invention The present invention includes a molded article for making lenses, which includes: mainly including or containing a lipid-copolymer, wherein the lipid-copolymer Including: mainly containing or containing at least two alicyclic monomers with different chemical structures. As used in this specification, the term "lens" refers to any eye device that is placed in or on the eye 'and these devices can provide optical bridges or make-up. Lens-The term includes but is not limited to: soft contact lenses, intraocular lenses, cover lenses, eye inlays, and optical inlays. The invented preferred mirror M is a Weapon body or a hydrogel-like contact lens, which includes, but is not affected by, the hydrogel and fluorine hydrogel. The formula of soft fe-shaped glasses is disclosed in: U.S. Patent 5,71,302, WO9421698, EP 4G6161, [p2G () () () 169 () 5, U.S. Patent 5,998,498, U.S. Patent Application Serial No. 9 / 957,299, dated September 20, 2008, Shen Yan, US Patent Application No. 09 / 532,943, US Patent-5-200534982 A7 B7 V. Description of Invention (4) 10 15 Employees ’Cooperatives, Intellectual Property Bureau, Ministry of Economic Affairs Printed 20,087,4, 5, US Patent 5,760,100, US Patent 5,776,999, US Patent 5,789,461, US Patent 5,849,811, and US Patent 5,965,631. Other polymers that can be used to generate soft contact lenses are disclosed in U.S. Patents 6,419,858, 6,308,314, and 6,416,690, and the entire contents of the aforementioned references are incorporated herein by reference. Particularly preferred lenses in the invention are: etafilcon A, genfilcon A, lenefilcon A, polymacon, acquafilcon A, balafilcon A, lotrafilcon A, galyfilcon A, and senofilcon A. The preparation of the silicone hydrogel is as follows: U.S. Patent No. 5,998,498, U.S. Patent Application No. 09 / 532,943, which is a continuation of the part of U.S. Patent Application No. 09 / 532,943 filed on August 30, 2000. Patent No. 09 / 957,299 was filed on September 20, 2001. The preparation of soft contact lenses is as follows: US Patent Application No. 60 / 318,536, titled "Biomedical Device Containing Internal Wetting Agent", applied on September 10, 2001, non-temporary with the same name Supplement 'was filed on September 6, 2002, U.S. Patent 6,087,415, U.S. Patent 5,760,100, U.S. Patent 5,776,999, U.S. Patent 5,789,461, U.S. Patent 5,849,8n, and U.S. Patent 5,965,63. The entire text of these patents (and applications) and all other patents disclosed in this application are incorporated herein by reference. As used in this specification, the term alicyclic monomer, means a polymerizable compound having at least one saturated carbocyclic ring, which can be replaced by one or more members of the following groups : Hydrogen, CM0 alkynyl, halogen, hydrogen, CM0 alkynyl, C | -10 alkynyl, ammonium, amino, iminium, silane, and optionally CI1G alkyl, which substitutes -6-6 A7 B7 2Θ0534982 V. Description of the invention (It is a member selected from one or more of the following groups, including: halogen, meridian, cM0, carbamoyl, cMGoxy, cyano, Amido, imino, and crushed. Examples of alicyclic monomers include, but are not limited to: polymerizable cyclobutane, cyclopentane'cyclohexane, cycloheptane, cyclooctane Alkane, bicyclobutane, dicyclopentane, bicyclohexane, bicycloheptane, bicyclooctane, and original borneol. The difficult person secrets at least two photomonomers, and then undergoes a hydrogenation reaction after ring-opening substitution. Because Copolymers are very expensive, so it is difficult to replace a single one 10 times. When using a typical number, it can be used more than— The present invention is preferably a molded lens was prepared comprising a saturated aliphatic carbon rings which were not limited to the following structure-limb of which particularly preferred examples include, but 15
r1 R4 ;r1 R4;
絰齊郎智慧財產局員Η消費合作社印製 20Printed by a member of the Qiqilang Intellectual Property Bureau and Consumer Cooperatives 20
其中among them
各自獨立地選自 :與R1Each independently selected from: and R1
個或多個下列群組之成 200534982 A7 B7 五、發明說明(6) 員,包括··氫、Ci_i〇烧基、鹵素、經基、Cm〇烧氧基罗反 基、CM〇烷氧基、氰基、醯胺基、醯亞胺基、矽烷基、與 取代之CM〇烷基,其取代基係選自一個或多個下列群組 之成員,包括:齒素、羥基、Cl_1G烷氧基羰基、CMG烷氧 基、氰基、醯胺基、醯亞胺基、與矽烷基。此外,二個或 夕個R叮/、同生成一未飽和鍵、碳環、包含《一個或多個 未飽和鍵之碳環、或芳族環。較佳之Rl_6為選自群組包括: CM〇烷基、與取代之烷基,其中取代基係選自群組 包括:鹵素、羥基、Cl-ι。烷氧基羰基、c,_l0烷氧基、氰 基、醯絲、醢亞胺基、與魏基。 H亂 脂環狀共聚物包括至少二個 v 物包含二個或, 15 20The composition of one or more of the following groups: 200534982 A7 B7 V. Description of the invention (6) members, including ... hydrogen, Ci_iO alkyl, halogen, meridian, Cmoxy alkoxyl, CM〇 alkoxy , Cyano, amido, amido, silyl, and substituted CMO alkyl, the substituents of which are selected from one or more of the following groups of members, including: halo, hydroxyl, Cl_1G alkoxy Carbonyl, CMG alkoxy, cyano, amido, amido, and silyl. In addition, two or more R atoms, together, form an unsaturated bond, a carbocyclic ring, a carbocyclic ring containing one or more unsaturated bonds, or an aromatic ring. Preferably, R1-6 is selected from the group consisting of: CM alkyl, and substituted alkyl, wherein the substituent is selected from the group consisting of: halogen, hydroxyl, Cl-ι. Alkoxycarbonyl, c, -10 alkoxy, cyano, reeling, fluorenimine, and weyl. H alicyclic copolymers include at least two v substances containing two or, 15 20
裝 訂 •8- 200534982 A7 B7 10 15 絰濟邹智慧財產局員工消費合作社印製 20 五、發明說明(7 )Binding • 8- 200534982 A7 B7 10 15 Printed by Jiuzou Intellectual Property Bureau Employee Consumer Cooperatives 20 V. Description of Invention (7)
月曰環狀單體之飽和碳環具有式r1r&《共通結構,及 1^-1^4為 Cwo 烷基。 月曰環狀共聚物典型之表面能量,於25°C為介於30與 45達因/公分之間。最佳之脂環狀共聚物包含二個不同的 月曰環狀單體,由Zeon Chemicals L.P·公司以商品名 ZEONOR販售。ZE〇N〇R有數個不同的等級,具有玻璃The saturated carbocyclic ring of the cyclic monomer has the formula r1r & common structure, and 1 ^ -1 ^ 4 is a Cwo alkyl group. The typical surface energy of a cyclic copolymer is between 30 and 45 dyne / cm at 25 ° C. The best alicyclic copolymer contains two different cyclic monomers and is sold by Zeon Chemicals L.P. under the trade name ZEONOR. ZE〇NO〇R comes in several different grades with glass
癌轉移溫度105-160°C,特佳之ZEONOR為ZEONOR 1060R ’ 依照製造商,Zeon Chemicals L.P·公司,其g 熔體流動速率(“MFR”)之範圍為lh0公克/1〇分鐘至 公克分鐘(依JISK 6719測試(230Χ:)),比重(水=1)¾ 1·〇1,與玻璃態轉移溫度為1〇5。〇。 本說明書中所使用之,,模塑物”一詞,係指一種硬質物 件,其可用於由未熟化配方生成鏡片者。較佳之模塑物為 如前所述之二部件模塑物,模塑物之正面曲線狀物或背面 曲線狀物由依本發明之脂環狀共聚物製得,其他的曲線狀 物製自聚丙稀,聚丙稀之實例包括,但未受其偈限:由金 屬雙環物戊一稀絡合物催化之聚丙烯,並經核化與淨化, 例如,但未受其侷限:得自Exxon之Achieve 1615與 ATOFINA EOD 00-11 〇製作依本發明模塑物之車交佳方法 為藉使用省知技術之注射模塑’但是製作模塑物亦可使用 其他技術,如:車床加工、金鋼石車削、或激光切割。 -9- A7 B7 200534982 五、發明說明(8 ) 典型地,鏡片係於模塑物二部件之各至少一表面上生 成,然而,若有需要,鏡片之—表面可由模塑物生成另 一表面可使用車床加工法或其他方法生成。 10 15 經濟部智慧財產局員工消費合作社印製 20 除了脂環狀共聚物外,依本發明模塑物可包含添加 物,其能使鏡片生成之表面分離,或降低曲線狀鏡片對於 模塑物表面之«性,或為二者,例如:可在熟化該聚合 物以生成模塑物前,將添加物如:硬脂酸之金屬或銨鹽、 醯胺蠟、聚乙烯或聚丙烯蠟、有機磷酸酯、甘油酯、或醇 酯加至脂環狀共聚物中。此類添加物之實例包括,但未受 其侷限:Dow矽氧烷MB50-321(—種矽氧烷分散劑)、 Nurcrel 535 & 932(乙烯-甲基丙烯酸共聚物樹脂,‘冊編 號25〇53·53·6)、Erucamide(脂肪酸醯胺,註冊編號ι12· 84-5)、Oleamide(脂肪酸醯胺,註冊編號301-02-0)、 Mica(註冊編號12001-26-2)、Atmer 163(脂肪烷基二乙醇 胺,註冊編號107043-84-5)、Pluronic(聚氧基伸丙基-聚氧 基伸乙基嵌段共聚物,註冊編號106392-12-5)、 Tetronic(烷氧化胺,110617-70-4)、Flura(註冊編號 7681-49-4)、硬脂酸約、硬脂酸辞、Super-floss防黏連劑(滑爽/ 防黏連劑,註冊編號61790-53-2)、Zeosphere防黏連劑(滑 爽/防黏連劑)、Ampacet 40604(脂肪酸醯胺)、 Kemamide(脂肪酸醯胺)、Licowax脂肪酸醯胺、Hypermer B246SF、XNAP、聚單月桂酸乙二醇酯(抗靜電)、環氧化 之大豆油、滑石(水合之矽酸鎂)、碳酸鈣、山茶酸、四硬 脂酸季戊四醇醋、琥ϊέ酸、epolene E43-Wax、甲基纖維 -10- 200534982 B7 五、發明說明(9 ) ^— 素、cocamide(防黏連劑,註冊編號61789-19-3)、聚乙稀 基σ比洛烧_(分子量360,000),與揭示於美國專利 5,690,865中之添加物,故將其全文併入本文供參考。較 佳之添加物為聚乙烯基吡咯烷酮、硬脂酸鋅、與單硬脂酸 5 甘油酯,其添加物之重量百分率,以聚合物之總重為基 準,為約0·05至約10.0重量百分率,以約0·05至約3〇 马季父侄,以約2.0重量百分率為最佳。 10 15 除添加物外,鏡片生成表面之分離,可藉將界面活十 劑施加至鏡#生成表面而達成,適合的界面活性劑實例^ 括:Tween界面活性劑,特別是如敘述於美國專身 5,837,314之Tween 8〇,故將其全文併入本文供參參》 他的界面活性劑實例揭示於美國專利5,264·161,因此才 將其全文併入本文供參考。 此外’除了脂環狀共聚物外,依本發明_物尚可€ 含其他聚合物,例如:聚丙烯、聚乙稀、聚苯乙稀、聚? 基丙稀酸"'與於主鏈中包含—種脂環狀部份之經改s 聚烯烴,例如:可使用—種脂環狀共㈣與聚_之射 物(金屬雙環物戊二烯絡合物催化法,並經核化,使用 ΑΤΟΠΝΑ EOD 0(M1),其脂環狀共聚物對於聚丙稀重量 百分率之比率範圍分別自約99:1至約2_。此推合物习 祕模塑物半部件中之_或二者,較佳者為將此推合物用 於匕含脂城絲物之“轉錄與正面轉狀物。 =明另外包括—㈣作鏡片之妓,包括主要包 括或士W-種未鼠之鏡#财分散於難物之表面 20 200534982 _______ B7 五、發明說明(10) 上’主要包括或包括:一種脂環狀共聚物,其中該脂環狀 共聚物包括··主要包括或包括:至少二個具有不同化學結構 之脂環狀單體,與2)於適合的條件下熟化該鏡片配方,鏡 片、脂環狀單體、與模塑物等名詞具有其前述之意義與較 5 佳範圍。 本說明書中所使用之”未熟化,,一詞,係指於最後熟化 以生成鏡片前,鏡片配方之物理狀態,某些包含單體混合 物之鏡片配方僅熟化一次。其他鏡片配方包含單體、部份 熟化之單體、大分子、與其他組份,此類部份熟化配方之 10 貫例揭示於:美國專利6,419,858、6,308,314、與 6,416,690,本發明可使用這些配方以及其他配方。:: 本說明書中所使用之,,於適合的條件下熟化,,一意吾,係 才曰使用任何熟化鏡片配方之習知方法,例如··使讀光、 熱、與適當的催化劑,以製造熟化鏡片,此類熟化條件之 15 汽例,可於本說明書中列示之軟質鏡片配方參考文獻中查 得。 此外,本發明亦包括一種鏡片,其製造方法包括:主 要包括或包括:1)將-種未熟化之鏡片配方分散於模塑物之 表面’主要包括或包括:―種脂環狀共聚物,其中該脂環 狀共聚物包括:主要包括或包括:至少二個具有不同化學結 構之脂環狀單體,與2)於適合的條件下熟化該鏡片配方, 鏡片、脂環狀單體、未熟化、與模塑物等名詞具有其前述 之意義與較佳範圍。 此外本發明尚包括一種模塑物,包括:主要包括或 -12- 200534982 a7 ______B7 _五、發明說明(7 ~—~~~- 包括:-種脂環狀共聚物’與至少—種生成鏡片之表面 其中該脂魏絲物,包括:主要包括或包於至少二 個具有不同化學結構之脂環狀單體,與 其中該至少-種生成鏡片之表面,包括:主要包括或 5 包括:―具有塗覆效果數量之高分子量塗覆組成物。 鏡片、脂環狀單體、未熟化、與模塑物等名詞具有其前述 之意義與較佳範圍。 ” ^ 、本說明書中所使用之,,生成鏡片之表面”,係指用以模 塑鏡片之表面,此表面具有一種光學品質之表面修飾,音 1〇 指其為充分地平滑,故由鏡片生成㈣與模塑物表^ 觸,經聚合反應生成之鏡片表面為光學地可接受。此外, 該表面具有一幾何形狀,其必須賦予鏡片表面所欲之光學 =性,包括,但未受其侷限:球形、非球形、與圓筒形2 才曰數、波前光行差之修正、comeal圖形之修正,與類同 15 者,以及其組合。 、 —高分子量”一詞意指足夠高之平均分子量(“Mw,,), 藉以防止塗覆物溶解於鏡片配方或模塑物材料中。為達成 本發明目的,較佳者為藉凝膠滲透色譜法(“Gpc,,)測定分 2〇 T量,使用一光散射偵測器與一高靈敏度折射指數偵測 0 器,例如:型號PL-RI,得自聚合物實驗室公司。GPC之 進行係使用一 5微米苯酚凝膠之線形管柱,其裝設具有相 同組份之護衛管柱,與一種〇·5重量百分率之溴化經於二 甲基甲谷液,做為洗提液,流速為每分鐘毫升, 其注射容積自約10至約20微升,所使用之精確分子量依 -13- A7 B7 200534982 ‘ \ _ 五、發明說明(I2 所選擇之塗覆物與所使用之單體混合物而定,於較佳之實 例中,塗覆物之分子量大於約300 kD。 本發明中可使用之,,塗覆組成物”,包括廣泛種類之習 知單體與聚合物,較佳者為使用:聚(乙烯醇)、聚環氧乙 烷、聚(曱基丙烯酸2-羥基乙酯)、聚(曱基丙烯酸甲酯)、 聚(丙烯酸)、聚(甲基丙烯酸)、聚(馬來酸)、聚(衣康酸)、 聚(丙烯醯胺)、聚(曱基丙烯醯胺)、聚(二甲基丙晞醯胺)、 聚(曱基丙烯酸甘油酯)、聚苯乙烯磺酸、聚磺酸酯聚合 物、聚(乙烯基吡咯烷酮)、羧基甲基化聚合物,如:羧基甲 10 15 經濟部智慧財產局員工消費合作社印製 20 基纖維素、多糖類、葡萄糖胺基烯糖、聚乳酸、聚乙醇 酉文七述者之肷#又或無規共聚物、與類同物、與索混合 物。較佳者為使用聚(甲基丙稀酸_基乙醋)、聚(控締基 轉細)、聚(丙烯酸)、聚(曱基丙稀酸)、聚(甲幻丙稀 醯胺、聚(丙烯酿胺),最佳者為使用聚(甲基丙稀酸 乙酯)。 “二高1 環合物外,塗覆組成物可包括-種低濟點 溶劑與—種高㈣(高於約靴)溶劑。適 :的=點溶劑包括’但未受其揭限:丙酮、氣仿、與醇 類,例如··甲醇、乙醇、異丙醇、 乐二丁醇、與類同物。 有用的高沸點溶劑包括,但未受复 s工甘’ 又卉侷限··甲基…乙基-、盥 八丙基她旨、乙稀與(聚)乙二醇、丙二醇、正_甲基轉 烷酮'二甲基甲醯胺、四氫香葉 土 ^ ^ ^ ^ ^ 卜丁醇、1-戊醇、1- 己知、1-辛醇、3-甲基各戊醇、二 T暴-3-辛醇、3-甲氣 基小丁醇、1,2-與M_丁二醇、 平虱 ,-已—酵、水、與類同 -14- 200534982 A7 B7 五、發明說明( 物。典型地,當塗覆於15與45°C間進行時,低對高沸點 溶劑之比率為約10:90至90:10。當使用旋轉塗覆施加塗 覆組成物時(討論於下),塗覆組成物包含低沸點與高沸點 溶劑中之一或二者。 10 15 經濟部智慧財產局員工消費合作社印製 20 此外,塗覆組成物可包括至少一種界面活性劑,適合 的界面活性劑包括,但未受其侷限:陰離子界面活性劑, 例如:羧酸鹽、磺酸鹽、硫酸鹽、磷酸與聚磷酸酯,陽離 子界面活性劑,例如:長鏈胺類與其鹽類、二胺、與聚胺 類、與其鹽類、四級胺鹽類、胺氧化物,非離子界面活性 劑,例如:聚氧基伸乙基化之烷基酚、烷基酚乙氧化物、 聚氧基伸乙基化之直鏈醇類、聚乙氧化之聚氧基丙^醇、 聚乙氧化之聚二曱基魏烧共聚物、氟化之鏈紅氧化物 共聚物、與長鏈羧酸酯類,兩性離子界面活性劑,例 如:pH-敏感與PH-不敏感之離子界面活性劑、與類同物、 與其組合。所細界面活性劑之特殊麵與數量,依塗覆 組成物之其他組份與所使狀模難表面而定,典型地, =塗覆組成物之總重為基準,使用高於鱗於約議i重 量%,與低於或等於約5重量%,之塗覆組成物。 塗覆組成物可藉任何適合的方法施加於模塑物表面, 包括,但未受其侷限:壓塑、塗抹、噴霧塗覆、喷墨印 刷、氣喷、喷霧、浸潰塗覆、旋轉塗覆、與類同者、録 組合’以使用旋轉塗覆為較佳,而且,較佳者為··在將i 用於生成㈣前,先覆物麵或使其科黏。可使用 任何適合的方法進行乾燥,較佳者為溫度高至約為模塑物 -15- 200534982The cancer metastasis temperature is 105-160 ° C. The best ZEONOR is ZEONOR 1060R. According to the manufacturer, Zeon Chemicals LP ·, its melt flow rate ("MFR") ranges from lh0 g / 10 minutes to g minutes ( According to JISK 6719 test (230 × :)), the specific gravity (water = 1) ¾ 1 · 〇1, and the glass transition temperature is 105. 〇. As used in this specification, the term "molded article" refers to a rigid object that can be used to produce lenses from uncured formulations. The preferred molded article is the two-part molded article described above. The front curve or the back curve of the plastic is made of the alicyclic copolymer according to the present invention, and other curves are made of polypropylene. Examples of polypropylene include, but are not limited by, the metal double ring Polypropylene catalyzed by pentylene complex, and nucleated and purified, for example, but not limited to it: Achieve 1615 and ATOFINA EOD 00-11 from Exxon. The best method is to use injection molding using provincial technology, but other techniques can also be used to make the molded product, such as lathe machining, diamond turning, or laser cutting. -9- A7 B7 200534982 V. Description of the invention (8 ) Typically, lenses are produced on at least one surface of each of the two parts of the molding, however, if necessary, the lens-surface can be produced from the molding and the other surface can be produced using lathe machining or other methods. 10 15 Ministry of Economic Affairs Printed by the Bureau ’s Consumer Cooperatives20 In addition to the alicyclic copolymer, the moldings according to the present invention may contain additives that can separate the surface produced by the lens, or reduce the properties of the curved lens on the surface of the molding, or For both, for example: before curing the polymer to form a molding, add additives such as: stearic acid metal or ammonium salt, ammonium wax, polyethylene or polypropylene wax, organic phosphate ester, glyceride , Or alcohol esters are added to alicyclic copolymers. Examples of such additives include, but are not limited to: Dow Siloxane MB50-321 (a kind of silicone dispersant), Nurcrel 535 & 932 ( Ethylene-Methacrylic Copolymer Resin, 'Book No. 25505 · 53 · 6), Erucamide (Fatty Acid Ammonium, Registration No. 12 · 84-5), Oleamide (Fatty Acid Ammonium, Registration No. 301-02-0) Mica (Registration No. 12001-26-2), Atmer 163 (Fat Alkyl Diethanolamine, Registration No. 107043-84-5), Pluronic (Polyoxypropylene-Polyoxyethylene Ethylene Block Copolymer, Registration No. 106392-12-5), Tetronic (amine alkoxide, 110617-70-4), Flura (registration number 7781-49-4), hard Acid acid, stearic acid, Super-floss anti-blocking agent (slip / anti-blocking agent, registration number 61790-53-2), Zeosphere anti-blocking agent (slip / anti-blocking agent), Ampacet 40604 (Fatty acid ammonium), Kemamide (fatty acid ammonium), Licowax fatty acid ammonium, Hypermer B246SF, XNAP, polyethylene glycol monolaurate (antistatic), epoxidized soybean oil, talc (magnesium silicate hydrate) , Calcium carbonate, camellic acid, pentaerythritol tetrastearate, succinic acid, epolene E43-Wax, methylcellulose-10- 200534982 B7 V. Description of the invention (9) ^-Element, cocamide (anti-adhesive agent, registration No. 61789-19-3), polyethylene sigma-pylon (molecular weight 360,000), and the additives disclosed in US Pat. No. 5,690,865, which are incorporated herein by reference in their entirety. Preferred additives are polyvinylpyrrolidone, zinc stearate, and 5 glyceryl monostearate. The weight percentages of the additives, based on the total weight of the polymer, are from about 0.05 to about 10.0 weight percent. With about 0.05 to about 30 Mati father and nephew, about 2.0 weight percent is the best. 10 15 In addition to the additives, the separation of the lens generating surface can be achieved by applying an interfacial active agent to the surface of the lens #. Examples of suitable surfactants include: Tween surfactants, especially as described in the United States Tween 80, which is 5,837,314, is hereby incorporated by reference in its entirety. Examples of his surfactants are disclosed in U.S. Patent 5,264.161, which is hereby incorporated by reference in its entirety. In addition, in addition to the alicyclic copolymer, according to the present invention, the material can also contain other polymers, such as: polypropylene, polyethylene, polystyrene, poly? Acrylic acid " 'and modified s polyolefins containing alicyclic components in the main chain, for example: you can use alicyclic cyclic copolyesters and poly (jectives) (metal bicyclic pentylene Ethylene complex catalyzed and nucleated using ΑΤΟΠΝΑ EOD 0 (M1), the ratio of its alicyclic copolymer to polypropylene weight percentage range from about 99: 1 to about 2_. One or both of the moulded half parts, preferably this pusher is used for the "transcription and frontal rotation of fat-containing silks." = In addition to include-prostitutes for lenses, including Mainly including or Shi W- 种 未 鼠 之 镜 #Cai scattered on the surface of difficult objects 20 200534982 _______ B7 V. Description of the invention (10) Mainly includes or includes: an alicyclic copolymer, wherein the alicyclic copolymer Include ... Mainly include or include: at least two alicyclic monomers having different chemical structures, and 2) curing the lens formula under appropriate conditions, and the terms lens, alicyclic monomer, and moldings have Its foregoing meaning and a better range than 5. As used in this specification, the term "unripe," Refers to a lens formulation prior to final cure to generate a lens, the lens prescription of the physical state, some was aged monomer mixture comprising only once. Other lens formulations include monomers, partially cured monomers, macromolecules, and other components. Ten examples of such partially cured formulations are disclosed in: US Patents 6,419,858, 6,308,314, and 6,416,690. These formulations can be used in the present invention And other recipes. :: Used in this manual, matured under suitable conditions, is intended to use the conventional method of using any mature lens formula, such as making reading, heat, and appropriate catalysts to manufacture Cured lenses, 15 steam examples of such curing conditions can be found in the soft lens formulation references listed in this specification. In addition, the present invention also includes a lens, the manufacturing method of which includes: 1) Dispersing an uncured lens formula on the surface of a molded object, which includes or includes:-an alicyclic copolymer, The alicyclic copolymer includes: mainly including or including: at least two alicyclic monomers having different chemical structures, and 2) curing the lens formula under suitable conditions, lenses, alicyclic monomers, and immature Terms such as chemical and molding have their aforementioned meanings and preferred ranges. In addition, the present invention also includes a molding, including: mainly including or -12-200534982 a7 ______B7 _V. Description of the invention (7 ~~~~~-Including:-a kind of alicyclic copolymer 'and at least-a kind of lens The surface of the fatty filament includes: mainly including or enclosing at least two alicyclic monomers having different chemical structures, and the surface where the at least one kind of lens is formed, including: mainly including or 5 including: ― High-molecular-weight coating composition with the number of coating effects. The terms lens, alicyclic monomer, uncured, and molding have their aforementioned meanings and preferred ranges. "^, Used in this specification, "The surface of the lens" refers to the surface used to mold the lens. This surface has a surface modification of optical quality. The tone 10 means that it is sufficiently smooth, so the lens produces a surface that touches the molded object. The surface of the lens produced by the polymerization reaction is optically acceptable. In addition, the surface has a geometric shape that must impart the desired optical properties to the surface of the lens, including, but not limited to: spherical, non-spherical, and cylindrical Shape 2 Correction of numbers, corrections of wavefront light aberrations, corrections of comeal patterns, the same as 15, and combinations thereof. The term "high molecular weight" means a sufficiently high average molecular weight ("Mw ,,") to prevent The coating is dissolved in the lens formulation or molding material. For the purpose of the invention, it is preferred to measure the amount of 20T by gel permeation chromatography ("Gpc,"), using a light scattering detector And a high-sensitivity refractive index detector 0, such as model PL-RI, available from Polymer Labs. GPC is performed using a 5 micron phenol gel linear column, which is installed with the same composition Guard column, 0.5% by weight bromide in dimethylformaniline as eluent, the flow rate is ml per minute, and its injection volume is from about 10 to about 20 microliters. The exact molecular weight is based on -13- A7 B7 200534982 '\ _ 5. Description of the invention (I2 The coating and the monomer mixture used are determined. In a preferred embodiment, the molecular weight of the coating is greater than about 300 kD. It can be used in the present invention, coating composition ", package A wide variety of conventional monomers and polymers, preferably used: poly (vinyl alcohol), polyethylene oxide, poly (2-hydroxyethyl methacrylate), poly (methyl methacrylate), Poly (acrylic acid), poly (methacrylic acid), poly (maleic acid), poly (itaconic acid), poly (acrylamide), poly (fluorenylacrylamide), poly (dimethylpropane) Amine), poly (fluorenyl acrylate), polystyrene sulfonic acid, polysulfonate polymer, poly (vinyl pyrrolidone), carboxymethylated polymer, such as: carboxymethyl 10 15 Intellectual Property Bureau, Ministry of Economic Affairs Employee Consumer Cooperatives printed 20-based cellulose, polysaccharides, glucosaminoglycans, polylactic acid, polyethanol, etc., or random copolymers, analogues, and cord mixtures. The preferred ones are poly (methacrylic acid-ethylacetate), poly (acrylic acid), poly (acrylic acid), poly (fluorenyl acrylic acid), poly (methramine, Poly (acrylic acid amine), the best is poly (ethyl methacrylate). "In addition to the two-high-1 cyclic compound, the coating composition may include- Higher than about boots) solvents. Suitable: = point solvents include 'but not limited by it: acetone, aerosol, and alcohols, such as · methanol, ethanol, isopropanol, radibutanol, and similar Useful high-boiling solvents include, but are not affected by, Gonggan's limitations: methyl ... ethyl-, octapropylpropyl, ethylene and (poly) ethylene glycol, propylene glycol, n- Methyltransferanone's dimethylformamide, tetrahydrogeranol ^ ^ ^ ^ ^ Butanol, 1-pentanol, 1-known, 1-octanol, 3-methyl isopentyl alcohol, Dioxol-3-octanol, 3-methylaminobutanol, 1,2- and M-butanediol, ticks, -hex-ferment, water, and the like-14-200534982 A7 B7 Description of the invention (typically, when coating between 15 and 45 ° C, low to high boiling point solvents The ratio is about 10:90 to 90:10. When the coating composition is applied using spin coating (discussed below), the coating composition contains one or both of a low boiling point solvent and a high boiling point solvent. 10 15 Ministry of Economic Affairs Printed by the Intellectual Property Bureau's Consumer Cooperatives20 In addition, the coating composition may include at least one surfactant, suitable surfactants include, but are not limited to: anionic surfactants, such as carboxylates, sulfonates , Sulfate, phosphoric acid and polyphosphate, cationic surfactants, such as: long-chain amines and their salts, diamines, and polyamines, and their salts, quaternary amine salts, amine oxides, non-ionic interfaces Active agents, such as: polyoxyalkylated alkylphenols, alkylphenol ethoxylates, polyoxyalkylated linear alcohols, polyethoxylated polyoxypropanols, polyethoxylated Polydifluorene-based sintered copolymer, fluorinated chain red oxide copolymer, and long-chain carboxylic acid esters, zwitterionic surfactants, such as pH-sensitive and pH-insensitive ionic surfactants, and Analogs, and combinations thereof. Of the fine surfactants The specific surface and quantity depend on the other components of the coating composition and the surface of the mold. Typically, = the total weight of the coating composition is used as a basis, and the weight is higher than the scale to about i% by weight, and The coating composition is less than or equal to about 5% by weight. The coating composition can be applied to the surface of the molding by any suitable method, including, but not limited to: compression molding, painting, spray coating, spray coating Ink printing, air spraying, spraying, dip coating, spin coating, and the like, and recording combination are better to use spin coating, and more preferably, i is used to generate i First, cover the surface or make it sticky. It can be dried by any suitable method, preferably at a temperature as high as about -15-200534982
、發明說明( 材料之玻雜轉移溫度(“Tg”)下,於空氣或於直空下進 ;隨===度’至高約為模塑物材料之玻璃態轉移 2,與减心下,進行平衡。於真空«過程中,較 :者為使科敵㈣其他過㈣,叫止模塑物被污 染。 10 於旋轉塗覆法巾,較佳者為:紐組成物具有較模塑 表面之表面月匕里為低的表面張力。更佳者為:塗覆組成 物具有較祕域難表面之表·量為低,減大於3 ,因λ刀的表面張力,其係於施加塗覆物之溫度下測 夏。最佳者^賴纟域物具有較觀物表面之表面能量 為低,相差大於8達因/公分,的表面張力。 , 15 於-較佳的用以生成隱魏鏡之_麵法中|使用 旋轉塗覆以沉積-乾厚約為5至約7G奈米之塗覆|於模 塑物之模絲面上,若塗制之表面張力與模塑物之表面 能量,於施加塗覆物之溫度下測量,相差大於約8達因/ 公分時,適合的旋轉狀況為:至少約6,〇〇〇但不高於約 8.000 RPM ’使用至少約2但不高於約2〇微升之塗覆組成 物’並且至少旋轉約3秒鐘。若表面張力之差異少於約8 達因/公分時’模塑物旋轉到至少約3,000但不高於約 20 訂 5.000 RPM ’使用至少約2但不高於約1〇微升之塗覆組成 物’而後模塑物旋轉到至少約7,〇〇〇但不高於約1〇,〇〇〇 RPM,於停止前至少進行約3秒鐘。 任何積聚於模塑物邊緣之過量塗覆物,必須予以移 除’移除之進行可藉任何習知之方法,包括:但未受其侷 -16- 200534982 μ — ----- Β7 五、發明說明(15) 限··抹除過量物、使用真空、溶劑、清洗或加壓之空氣喷 嘴移除過量物,以使用空氣喷嘴移除過量物為較佳。緊要 的是:需在開啟噴嘴前啟動旋轉,而且,較佳者為·空氣喷 嘴之壓力等於或高於約3psi。 5 ‘有效塗覆用量”一詞意指塗覆組成物於鏡片生成表面 之厚度與糙度,對於水合之隱形眼鏡,較佳者為:水合鏡 片之尖峰至尖峰表面糙度,以低於約500奈米為較佳,因 此有效塗覆用ϊ意指塗覆組成物之用量,足以於鏡片生 成表面提供一塗覆組成物之乾膜厚度,其可得到用於隱形 10 眼鏡之具有可接受表面糙度之水合物件,以水合鏡片之尖 峰至乂峰表面链度低於約500奈米為較佳,更佳者為:所 使用塗覆組成物之數量為:其數量足以製造一厚度為至少 約5奈米,但不高於約7〇奈米之乾膜,以至少約5奈 米,但不高於約50奈米為較佳,以至少約2〇奈米,但不 15 向於約40奈米為更佳,最佳者為該有效塗覆用量可覆蓋 整個或主要地整個鏡片生成表面。 絰濟邹智慧財產局員工消費合作钍印製 可將塗覆添加物加至依本發明之高分子量塗覆組成物 中,塗覆添加物可包括,但未受其侷限:著色劑、顏料、 與抗微生物組成物,可依此方式使用之抗微生物組成物實 20 例,揭示於下列美國專利與申請案件中,因此將其全文併 入本文供參考··美國專利 6,218,492,6,248,811,6,160,056 與於2001年12月20日申請之美國專利申請案號 10/028,400,名稱為抗微生物之隱形眼鏡與其製造方法, 與於2001年12月21日申請之1〇/〇29,526,名稱為抗微 -17- A7 B7 200534982 五、發明說明(16 生物之隱形眼鏡與其使用方法。 本發明另外包括一種製作塗覆鏡片之方法,兑勺 主要包括或包括: 〃已· (1) 於鏡片模塑物之至少一個鏡片生成表面,使用有效塗 覆用量之高分子量塗覆組成物予以塗覆,其中节梦片 模塑物包括一種脂環狀共聚物,與至少一個鏡片生 表面, 其中該脂環狀共聚物包括,主要包括或包括:至 少二種不同化學結構之脂環狀單體, 10 15 經濟部智慧財產局員工消費合作社印製 20 (2) 將一種未熟化之鏡片配方分散於該至少一個鏡片生成 表面上,與 (3) 熟化該鏡片配方與該塗覆組成物,於適合生成塗覆鏡 片之條件下進行,使用少於5分鐘之駐留時間。 鏡片、脂環狀單體、未熟化、模塑物、高分子量、塗覆組 成物、與有效塗覆用量等名詞,皆具有其前述之意義與較 佳範圍。 ^ 為了說明本發明,故包括下列實例,但這些實例不侷 限本發明,其意義僅為建議一種應用本發明之方法,那些 對於製造鏡片以及其他專長之博學人士可發現其他應用本 發明之方法,然而,這些方法應被視為屬於本發明範圍 内0 實例 於諸實例中,使用下列縮寫 -18- 200534982 B7 五、發明說明(17 ) BC 背面曲線 藍色-HEM A 藉曱基丙烯酸羥基乙酯,將反應性藍色#4 之一個氣化物進行鹼促進置換反應獲得 之產物 5 CIP 預熟化 CGI 1850 1-羥基環己基苯基酮與雙(2,6-二甲氧基 卞2监基)-2,4,4-二甲基戍基鱗乳化物之 1:1(重量)摻合物 CGI 819 雙(2,4,6-三甲基苄醯基)苯基膦氧化物 10 D3〇 3,7·二甲基-3-辛醇 Darocur 1173 汽巴特用化學品公司之紫外線光引發劑 DMA N,N-二甲基丙醯胺 .V: FC 正面曲線 ATOFINA EOD 00-11 —種金屬雙環戊二烯絡合物與等規 15 聚丙烯,具有熔體流速14-18公克/10分 鐘,ASTM D1238 HEMA 曱基丙烯酸2_羥基乙酯 IPA 異丙醇 大分子2 欽述於下者之實例中之反應產物:於2001 20 年12月20曰申請之美國專利申請序號 10/028,400,名稱為:抗微生物隱形眼鏡 與其製造方法 mPDMS 端基為單甲基丙稀基氧基丙基之聚二曱 基矽氧烷 -19- 200534982 A7 B7 五、發明說明(ι〇、 Explanation of the invention (The glass transition temperature ("Tg") of the material, under the air or in the direct space; with === degrees' up to about the glass transition of the molding material2, and under the heart, Equilibrium. In the process of vacuum «, the comparison is to make the enemy more difficult to stop the moldings from being contaminated. 10 For spin-coating towels, the better is: the button composition has a more molded surface The surface has a low surface tension. The better is: the coating composition has a surface that is more difficult than the secret area. The amount is low, less than 3, due to the surface tension of the lambda knife, which is applied to the coating. Measured at the temperature of the object. The best one is the surface energy of the surface of the object, which is lower than the surface energy of the object, the difference is greater than 8 dyne / cm, and the surface tension is better. _In the surface method | Use spin coating to deposit-dry thickness of about 5 to about 7G nanometers | on the silk surface of the molding, if the surface tension of the coating and the surface energy of the molding, Measured at the temperature at which the coating is applied, when the difference is greater than about 8 dyne / cm, suitable rotation conditions are: at least about 6,000 but not high At about 8.000 RPM 'use at least about 2 but no more than about 20 microliters of coating composition' and rotate for at least about 3 seconds. If the difference in surface tension is less than about 8 dyne / cm 'molded Rotate to at least about 3,000 but not more than about 20. Order 5.000 RPM 'use at least about 2 but not more than about 10 microliters of coating composition' and then mold to rotate to at least about 7,000 but not high At about 10,000 RPM, at least about 3 seconds before stopping. Any excess coating that has accumulated on the edges of the molding must be removed. The removal can be performed by any conventional method, including : But not subject to the situation -16- 200534982 μ — ----- Β7 V. Description of the invention (15) Limitation · Wipe off excess material, use vacuum, solvent, cleaning or pressurized air nozzle to remove excess material, It is better to use an air nozzle to remove the excess. It is important to start the rotation before opening the nozzle, and more preferably, the pressure of the air nozzle is equal to or higher than about 3 psi. 5 'Effective coating amount "- The word means the thickness and roughness of the coating composition on the lens generating surface, which is hidden from hydration. Spectacles are preferred: the peak-to-peak surface roughness of the hydrated lens is preferably less than about 500 nanometers, so effective coating means that the amount of coating composition is sufficient to provide a surface for the lens The dry film thickness of the coating composition can be used to obtain hydrated pieces with acceptable surface roughness for contact lens 10. It is preferred that the surface chain of the peak to peak of the hydrated lens is less than about 500 nm, and more The preferred one is: the amount of the coating composition used is sufficient to produce a dry film having a thickness of at least about 5 nm, but not higher than about 70 nm, and at least about 5 nm, but not high It is preferably about 50 nm, more preferably at least about 20 nm, but not more than about 40 nm, and the most effective is that the effective coating amount can cover the entire or mainly the entire lens generation surface. The consumer cooperation of the Jiuzou Intellectual Property Bureau. Printing can add coating additives to the high molecular weight coating composition according to the present invention. The coating additives can include, but are not limited by, colorants, pigments, And antimicrobial composition, 20 cases of antimicrobial composition that can be used in this way are disclosed in the following U.S. patents and applications, which are hereby incorporated by reference in their entirety. U.S. Patents 6,218,492, 6,248,811, 6,160,056 With US Patent Application No. 10 / 028,400, filed on December 20, 2001, named Antimicrobial Contact Lenses and Manufacturing Method thereof, and 10 / 〇29,526, filed on December 21, 2001, named Anti-Microbeam -17- A7 B7 200534982 V. Description of the invention (16 biological contact lenses and methods of using the same. The present invention also includes a method for making coated lenses, the spoon mainly includes or includes: (1) in the lens molding At least one lens-forming surface is coated with a high molecular weight coating composition in an effective coating amount, wherein the dream film molding comprises an alicyclic copolymer, and at least one The raw surface of the lens, wherein the alicyclic copolymer includes, mainly includes or includes: at least two alicyclic monomers of different chemical structures, 10 15 printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs 20 (2) a kind of immature The chemical lens formula is dispersed on the at least one lens generating surface, and (3) curing the lens formula and the coating composition is performed under conditions suitable for generating a coated lens, using a residence time of less than 5 minutes. , Alicyclic monomer, uncured, molding, high molecular weight, coating composition, and effective coating amount all have their aforementioned meanings and preferred ranges. ^ In order to illustrate the present invention, it includes the following Examples, but these examples are not limited to the present invention, and their significance is only to suggest a method for applying the present invention. Those skilled in the manufacturing of lenses and other expertise can find other methods of applying the present invention. However, these methods should be considered as belonging to Within the scope of the present invention, 0 Examples are used in the examples, and the following abbreviations are used: -18- 200534982 B7 V. Description of the invention (17) BC back curve blue -HEM A The product obtained by subjecting one gaseous substance of reactive blue # 4 to a base-facilitated substitution reaction by using hydroxyethyl acrylate, 5 CIP pre-cure CGI 1850 1-hydroxycyclohexylphenyl ketone and bis (2,6 -Dimethoxyfluorenyl 2monyl) 1: 1 (by weight) blend of 2,4,4-dimethylfluorenyl scale emulsion CGI 819 bis (2,4,6-trimethylbenzylhydrazone) Group) Phenylphosphine oxide 10 D3 03,7 · dimethyl-3-octanol Darocur 1173 DMA N, N-dimethylpropanamide, an ultraviolet photoinitiator of Cibaite Chemical Company. V: FC Frontal curve ATOFINA EOD 00-11 — a metal dicyclopentadiene complex with isotactic 15 polypropylene with a melt flow rate of 14-18 g / 10 minutes, ASTM D1238 HEMA 2-hydroxyethyl methacrylate IPA isopropyl Alcohol macromolecule 2 The reaction product described in the example below: U.S. Patent Application No. 10 / 028,400, filed on December 20, 2001, named: Antimicrobial Contact Lenses and Its Manufacturing Method Polyacrylyloxypropyl 19-200534982 A7 B7 V. Description of the invention (ι〇
m-PDMS-OHm-PDMS-OH
Norbloc PVP 聚-Hema SIGMA 10 15Norbloc PVP Poly-Hema SIGMA 10 15
TEGDMA TrEGDMA TBACB THF TMI TRIS 端基為單-(3-甲基丙烯基氧基-2-羥基丙 基氧基)丙基之端基為單·丁基之聚二甲基 矽氧烷(MW 1100) 2-(2’-羥基-5-甲基丙烯基氧基乙基苯基)-2H-笨並三。坐 聚(Ν-乙烯基吡咯烷酮) 聚羥基乙基甲基丙烯酸酯,具有分子量 大於1ΜΜ道爾頓 2- 丙酸,2-曱基-,2-羥基-3-[3-[1,3,3,3-四 甲基-1-[(三曱基矽烷基)氧基]二矽氧烷基] 丙氧基]丙酯 二曱基丙稀酸四乙二醇酯 二甲基丙烯酸三乙二醇酯 間-氣笨曱酸四丁基銨 四氫呋喃 3- 異丙烯基-α,α -二曱基苄基異氰酸酯 3-甲基丙烯基氧基丙基三_(三曱基矽氧 基)石夕烷 痤齊郎替慧財產咼貝工消费合作;ϋ印製 20 實例1 使用脂環狀共聚物製備模塑物 將脂環狀共聚物ZEONOR® 1060R之粒料置入一 9〇。(: 之除溼乾燥器中約一至四(1_4)小時,隨後經由一注射模塑 機將材料加熱與清除,使用一般地敘述於注射模塑手冊中 -20- 200534982 ^ ____ B7 五、發明說明(19) 之技術 ’ Dominick 與 Donald Rosato 編輯,1986 年由 NanTEGDMA TrEGDMA TBACB THF TMI TRIS Mono- (3-methacryloxy-2-hydroxypropyloxy) propyl end group Mono-dimethyl polydimethylsiloxane (MW 1100 ) 2- (2'-hydroxy-5-methacryloxyethylphenyl) -2H-benzyl. Poly (N-vinylpyrrolidone) polyhydroxyethyl methacrylate, with a molecular weight greater than 1MM Dalton 2-propanoic acid, 2-fluorenyl-, 2-hydroxy-3- [3- [1,3, 3,3-tetramethyl-1-[(trimethylsilyl) oxy] disilaxyl] propoxy] propyl ester difluorenyl acrylate tetraethylene glycol diethyl methacrylate Glycol Ester-tetrabutylammonium tetrahydrofuran 3-isopropenyl-α, α-difluorenylbenzyl isocyanate 3-methacryloxypropyltri- (trimethylsilyloxy) Shixuan acne and ziqilang cooperate on behalf of the Hui property and the shellfish consumer; print 20 Example 1 Use a cycloaliphatic copolymer to prepare a molded product. Place pellets of the cycloaliphatic copolymer ZEONOR® 1060R into 90. (: About one to four (1_4) hours in a desiccant dryer, followed by heating and removing the material through an injection molding machine, using the general description in the injection molding manual-20- 200534982 ^ ____ B7 V. Description of the invention (19) Technology 'Edited by Dominick and Donald Rosato, 1986 by Nan
Nostmnd Reinhold公司出版。大約有三(3)磅材料被清除, 並於10至15分鐘内予以模塑,得到放大率為-1〇〇 D之 鏡片之正面曲線物與背面曲線物。可重新獲得正常可使用 5 之鏡片模塑物,並且依照實例2之程序用其製作鏡片。 實例2 使用列示於表A中之配方製備矽氧烷水凝膠鏡片,其 精確混合程序之進一步細節,揭示於2〇〇1年9月2〇曰申 10 請之美國專利申請序號09/957,299中。Published by Nostmnd Reinhold. Approximately three (3) pounds of material were removed and molded within 10 to 15 minutes to obtain a front curve and a back curve of a lens with a magnification of -100 D. A lens mold 5 which is normally usable can be recovered and used to make lenses in accordance with the procedure of Example 2. Example 2 Further details of the precise mixing procedure for the preparation of a silicone hydrogel lens using the formulations listed in Table A are disclosed in US Patent Application No. 09 /, filed on September 20, 2001. 957,299.
表A 重量百分率 - ^分子2~^ 17.98 TRIS 14.00 DMA 26.00 MPDMS 28.00 TEGDMA 1.00 HEMA 5.00 PVP 5.00 NORBLOC 2.00 夏色HEMA ~ 0.02 CGI 1850 1.00 配方之其他部份為添加物與稀釋劑,單體對於稀釋劑 之比率為100:20,稀釋劑為3,7_二甲基辛醇,使用最終 混合物之1°/〇之乙酸,藉以安定單體。 -21- 200534982 A7 B7 五、發明說明(2〇 10 15 將依實例1方法製備之正面與背面曲線模塑物,以高 分子量聚HEMA塗覆物加以塗覆。藉於8000 rpm下旋轉 塗覆8秒鐘,將大約6微升之1.3重量%之聚HEMA於 70:30乙醇:乳酸乙酯溶液,施加於正面曲線模塑物之表面 (凹面)。於旋轉週期之最後2秒鐘,在旋轉部件之邊緣施 加空氣噴射,以移除過量的塗覆物。藉於6000 rpm下旋 轉塗覆2秒鐘,繼而於8000 rpm下6秒鐘,將大約8.5微 升之1·1 %之聚HEMA於70:30乙醇:乳酸乙酯溶液,施加 於背面曲線模塑物之表面(凸面)。於旋轉週期之最後2秒 鐘,在旋轉部件之邊緣施加空氣喷射,以移除過量的塗覆 物。鏡片之製作,係將前述之鏡片配方加於鏡片模塑物 中’關閉部件,在45°C於可見光下預熟化45秒鐘,隨後 在70°C於可見光下熟化7分鐘,對於所有的案例,在將 鏡片單體劑量加至模塑物後30秒鐘内,開始進行預熟 化。 鏡片經臨床試驗發現與ACUVUE etafilcon A鏡片具 有相等的眼上可溼潤性、或扯裂分開時間、與耐沉積性, 顯示將塗覆物施加至鏡片能獲得生理可相容之鏡片。 裝 訂 绥濟部智慧財產局員工消貲合作社印製 20 實例3 聚丙烯鏡片模塑物之製備 使用實例1之方法製備鏡片模塑物之正面曲線與背面 曲線’並以聚丙稀(Atofina公司製造之EOD 00-11)取代實 例1中之脂環狀共聚物。 -22- A7 B7 200534982 五、發明說明(21) 實例4 使用實例3之模塑物製備鏡片 鏡片之製備使用實例2之配方與方法,但以實例3模 塑物取代實例1之模塑物。完工之鏡片使用—種目視檢驗 設備,檢查塗覆物上的缺陷,缺陷為完工鏡片表面上未施 加塗覆物的分離區域,計算缺陷百分率並記錄於下示之表 B中。此實例顯示:製自脂環狀共聚物之模塑物可用於製 造塗覆鏡片,其具有大幅降低的塗覆缺陷。Table A Weight percentage-^ Molecule 2 ~ ^ 17.98 TRIS 14.00 DMA 26.00 MPDMS 28.00 TEGDMA 1.00 HEMA 5.00 PVP 5.00 NORBLOC 2.00 Summer HEMA ~ 0.02 CGI 1850 1.00 The other parts of the formula are additives and diluents, monomers for diluents The ratio was 100: 20, the diluent was 3,7-dimethyloctanol, and 1 ° / 0 acetic acid in the final mixture was used to stabilize the monomer. -21- 200534982 A7 B7 V. Description of the invention (2010 15 The front and back curve moldings prepared according to the method of Example 1 will be coated with a high molecular weight poly HEMA coating. By spin coating at 8000 rpm For 8 seconds, apply approximately 6 microliters of 1.3% by weight polyHEMA in a 70:30 ethanol: ethyl lactate solution to the surface (concave surface) of the front curve molding. During the last 2 seconds of the rotation cycle, An air jet was applied to the edge of the rotating part to remove excess coating. By spin-coating at 6000 rpm for 2 seconds, and then at 8000 rpm for 6 seconds, approximately 8.5 microliters of 1.1% were aggregated HEMA at 70:30 ethanol: ethyl lactate solution, applied to the surface of the back curve molding (convex). During the last 2 seconds of the rotation cycle, an air jet is applied to the edge of the rotating part to remove excess coating The lens is made by adding the aforementioned lens formulation to the lens mold to 'close the part, pre-cure at 45 ° C under visible light for 45 seconds, and then at 70 ° C under visible light for 7 minutes. For all Case, after adding the lens monomer dose to the molding 30 Within seconds, pre-maturation begins. The clinical test found that the lens has the same wettability on the eye as ACUVUE etafilcon A lens, or the tearing apart time, and the resistance to deposition, showing that the application of the coating to the lens can achieve physiological Compatible lenses. Binding printed by employees of the Intellectual Property Bureau of the Ministry of Suiji 20 printed by the cooperative. Example 3 Preparation of polypropylene lens moldings. The front and back curves of lens moldings were prepared using the method of Example 1 and polypropylene was used. Diluted (EOD 00-11 manufactured by Atofina) to replace the alicyclic copolymer in Example 1. -22- A7 B7 200534982 V. Description of the invention (21) Example 4 Preparation of lens using the molded article of Example 3 The formulation and method of Example 2, but the molding of Example 1 is replaced by the molding of Example 3. The finished lens is used-a visual inspection device to check for defects on the coating. The defect is that no coating is applied on the surface of the finished lens Area of the object, the percentage of defects is calculated and recorded in Table B shown below. This example shows that a molded product made from an alicyclic copolymer can be used to make coated lenses, which has a large Reduced coating defects.
10 經濟部智慧財產局員工消費合阼社印製 實例5 20 於正面曲線與背面曲線使科同模塑物㈣製得之鏡片 使用實例1與3方法製得之正面曲線與背面曲線模塑 物’依實例2之方法製備鏡片。如表c所示,使用 的模塑物㈣製作-些㈣,並败其麵顧比率與模 糊度。所示_度數值之測定,係將職制置於—位處 -23- 22 200534982 五 發明說明 埤 黑色背景上方之透明小室之鹽水中,以光纖燈自垂直於鏡 片小室66。之角度,由下方照明,並使用錄影相機自上方 攝取鏡片之影像。經減除背景之散射光影像,以下法予以 疋里分析:將鏡片中央1〇毫米區域進行積分,而後與一具 有-ι·〇〇折光度之CSI薄鏡片(市售鏡片,製造者為·Wesley J_n,33 East Tower A,Des Planes,伊利諾州)相比 較,後者之模糊度數值任意地設定為100,無鏡片之模糊 度數值設定為此數據顯示:當正面曲線與背面曲線模塑 物製自一種脂環狀共聚物時,產生最低數目之缺陷。 1010 Example printed by the Consumer Property Agency of the Intellectual Property Bureau of the Ministry of Economic Affairs 5 20 Lenses made by Koto Molding on the front curve and the back curve Using front curve and back curve moldings produced using the methods 1 and 3 'Lens was prepared according to the method of Example 2. As shown in Table c, some moldings were used to make some of them, and their face-to-face ratio and blur were reduced. The measurement of the value shown in the figure is to place the job system in place. -23- 22 200534982 V. Description of the invention 埤 In the salt water of the transparent chamber above the black background, the fiber optic lamp is perpendicular to the mirror chamber 66. The angle is illuminated from below, and the image of the lens is taken from above using a video camera. After subtracting the scattered light image of the background, the following method was used to analyze it: The 10 mm area in the center of the lens was integrated, and then it was combined with a CSI thin lens (commercially available lens, with a -ι · 0.00 refractive index) Compared with Wesley J_n, 33 East Tower A, Des Planes, Illinois), the blur value of the latter is arbitrarily set to 100, and the blur value of the lens is set to this data. This data shows: When the front curve and the back curve are molded When produced from an alicyclic copolymer, a minimum number of defects occur. 10
ZEONORZEONOR
ZEONORZEONOR
PPPP
PPPP
表C 塗覆缺陷 比率 0J%Ύ% 訂 60 30 1.4% 8.5 % d 31.2 經濟部智慧財產局員工消費合阼江印製 20 實例6 使用脂環狀共聚物製備鏡片模塑物 將脂環狀聚合物Ze〇nex® 480R之粒料置入一 10〇t:之 除座乾燥ϋ中約四(4)小時,試圖使用實例i方法生成模 塑物’但使用此材料無法生成有狀鏡片模塑物,僅得到 熟化材料之垂 ’而未生成鏡片模塑物之凹處。將模塑機 械之溫度增高(至顧安全下之最大程度),物村料之 溫度未能改正此難題,無法生成有用之模塑物。此實例顯 -24- 五、發明說明(23 ) 示由脂環狀共⑽成功_造模_與_觀聚 敗地製備模塑物間之差異。 口 實例7 5 製備推合之模塑物 將一數量之聚丙烯(八丁0_八£〇1>〇〇11,5〇%)與 ze〇n〇rl060R(50%)於一混合轉鼓中進行摻合,並°且持續 15分鐘,再將此混合物贿塑或造粒程序使生成均勾的 材料。將已摻合之材料置入注射模塑機器中,擠塑成鏡片 10 模塑物之公與母的半部件,隨後加以熟化,而且於使用前 將熟化之模塑物置於氮氣環境下30分鐘。 實例8 製備矽氧烷水凝膠鏡片B- 15 將列示於表D之諸反應組份與稀釋劑(D3〇)於約2rc 下,以攪拌或滾動加以混合至少約3小時,直至所有的組 伤均已浴解,反應組份係以其佔所有反應組份之重量百分 率予以記錄,稀釋劑則為最終反應混合物之重量百分率。 將反應混合物置入實例7之鏡片模塑物中,並在45〇c與氮 20 氣下,使用菲立浦TL20W/03T螢光燈泡予以照射,氮氣 操作箱中之熟化條件為:於約〇·2 mW/c2約6.5分鐘,隨後 於2.5 mWw/c2約12分鐘,氧含量低於15%氧氣。藉手動 打開模塑物,並評鑑鏡片,以決定熟化鏡片是否仍需駐留 於正面曲線或背面曲線模塑物中。表E列示每個鏡片模塑 200534982 A7 B7 五、發明說明(24 ) 物之半部件中Zeonor與聚丙烯(pp)之百分率,以及於二者 分離後,鏡片型號B仍舊駐留於正面曲線或背面曲線之鏡 片數目。Table C Coating defect ratio 0J% Ύ% Order 60 30 1.4% 8.5% d 31.2 Consumption by employees of the Intellectual Property Bureau of the Ministry of Economic Affairs, printed by Jiangxi 20 Example 6 Preparation of a lens molding using an alicyclic copolymer The alicyclic polymerization The pellets of Zeonex® 480R were placed in a 100 t: dry block of about four (4) hours. Attempts were made to use the method of Example i to produce a molded object, but the use of this material could not produce a shaped lens molding. Only the droop of the cured material was obtained without forming a recess for the lens molding. Increasing the temperature of the molding machine (to the greatest extent possible under safety), the temperature of the material cannot correct this problem, and it is impossible to produce a useful molding. This example shows -24- V. The description of the invention (23) shows the difference between the successful preparation of alicyclic _molding_ and _view polymerization to produce molded articles. Example 7 5 Preparation of a Push-Molded Product A quantity of polypropylene (octabutane 0-8) 〇011, 50%) and ze 00n060R (50%) in a mixing drum Blending was carried out for 15 minutes, and the mixture was then subjected to a plastic or granulation procedure to produce a homogeneous material. The blended material is placed in an injection molding machine, extruded into male and female half parts of the lens 10 mold, and then cured, and the cured mold is placed under a nitrogen atmosphere for 30 minutes before use . Example 8 Preparation of Silane Hydrogel Lens B-15 The reaction components listed in Table D and the diluent (D30) were mixed at about 2rc with stirring or rolling for at least about 3 hours until all All wounds have been bathed, and the reaction components are recorded as weight percentages of all reaction components. The diluent is the weight percentage of the final reaction mixture. The reaction mixture was placed in the lens molding of Example 7 and irradiated with a Phillips TL20W / 03T fluorescent bulb at 45 ° C and nitrogen 20 gas. The ripening conditions in a nitrogen operation box were: 2 mW / c2 for about 6.5 minutes, followed by 2.5 mWw / c2 for about 12 minutes, with an oxygen content below 15% oxygen. By manually opening the mold and evaluating the lens, determine whether the cured lens still needs to reside in the front curve or back curve mold. Table E lists the molding of each lens 200534982 A7 B7 V. The percentage of Zeonor and polypropylene (pp) in the half part of the invention description (24), and after the two are separated, the lens model B still resides in the front curve or Number of lenses in the back curve.
表D 鏡片種類 B C D E F G H I J K 組成物 SIGMA 28 30 28.6 28 31 32 29 39.4 20 68 PVP (K90) 7 10 7.1 7 7 7 6 6.7 3 7 DMA 24 17 24.5 23.5 20 20 24 16.4 37 22 mPDMS 31 32 0 31 31 34 31 29.8 15 0 TRIS 0 0 〇 0 0 0 0 0 15 0 HEMA 6 6 6.1 6 6.5 3 5.5 2.9 8 0 Norbloc 2 2 0 2.0 2 2 2 1.9 0 CGI 1850 0.48 1 1.02 1 1 1 1 1 1 0 ' TEGDMA 1.5 2 1.02 1.5 1.5 1 1.5 1.9 0 2 TrEGDMA 0 0 0 0 0 0 0 0 1 0 藍色HEMA 0.02 0 0 0 0 0 0 0 0 0 mPDMS-OH 0 0 31.6 0 0 0 0 0 0 0 Darocur 1173 0 0 0 0 0 0 0 0 0 1 D30% 23 26 17 23 23 29 32 28 17 27 -26- A7 200534982 五、發明說明(25 )Table D Lens type BCDEFGHIJK Composition SIGMA 28 30 28.6 28 31 32 29 39.4 20 68 PVP (K90) 7 10 7.1 7 7 7 6 6 6.7 3 7 DMA 24 17 24.5 23.5 20 20 24 16.4 37 22 mPDMS 31 32 0 31 31 34 31 29.8 15 0 TRIS 0 0 〇 0 0 0 0 0 15 0 HEMA 6 6 6.1 6 6.5 3 5.5 2.9 8 0 Norbloc 2 2 0 2.0 2 2 2 1.9 0 CGI 1850 0.48 1 1.02 1 1 1 1 1 1 0 'TEGDMA 1.5 2 1.02 1.5 1.5 1 1.5 1.9 0 2 TrEGDMA 0 0 0 0 0 0 0 0 1 0 Blue HEMA 0.02 0 0 0 0 0 0 0 0 0 mPDMS-OH 0 0 31.6 0 0 0 0 0 0 0 Darocur 1173 0 0 0 0 0 0 0 0 0 1 D30% 23 26 17 23 23 29 32 28 17 27 -26- A7 200534982 V. Description of the invention (25)
表E 背面曲線 正面曲線 正面曲線中之 鏡片% 測試總數 5% pp 95% Zeonor 100% Zeonor 29 24 25% pp 75% Zeonor 100% Zeonor 71 24 35% pp 65% Zeonor 100% Zeonor 88 24 35% pp 65% Zeonor 100% Zeonor 91 32 40% pp 60% Zeonor 100% Zeonor 97 32 40% pp 60% Zeonor 100% Zeonor 100 24 45% pp 55% Zeonor 100% Zeonor 100 32 50% pp 50% Zeonor 100% Zeonor 100 32 75% pp 25% Zeonor 100% Zeonor 100 32 此實例說明當摻合物中之聚丙烯數量增加時,黏附至 前曲面的鏡片數目增加。 經濟部智慧財產局員工消費合作社印製 -27- 本紙張尺度適用中國國家標準(CNS)A4規格(210x297公釐)Table E Back curve Front curve Lens in front curve% Total number of tests 5% pp 95% Zeonor 100% Zeonor 29 24 25% pp 75% Zeonor 100% Zeonor 71 24 35% pp 65% Zeonor 88 24 35% pp 65% Zeonor 100% Zeonor 91 32 40% pp 60% Zeonor 100% Zeonor 97 32 40% pp 60% Zeonor 100% Zeonor 100 24 45% pp 55% Zeonor 100% Zeonor 100 32 50% pp 50% Zeonor 100% Zeonor 100 32 75% pp 25% Zeonor 100% Zeonor 100 32 This example shows that as the amount of polypropylene in the blend increases, the number of lenses that adhere to the front curve increases. Printed by the Employees' Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs -27- This paper size applies to China National Standard (CNS) A4 (210x297 mm)
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW93110305A TW200534982A (en) | 2004-04-14 | 2004-04-14 | Molds for producing contact lenses |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW93110305A TW200534982A (en) | 2004-04-14 | 2004-04-14 | Molds for producing contact lenses |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200534982A true TW200534982A (en) | 2005-11-01 |
Family
ID=52348775
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW93110305A TW200534982A (en) | 2004-04-14 | 2004-04-14 | Molds for producing contact lenses |
Country Status (1)
Country | Link |
---|---|
TW (1) | TW200534982A (en) |
-
2004
- 2004-04-14 TW TW93110305A patent/TW200534982A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105334640B (en) | Silicone hydrogel lenses with rich water surface | |
TWI623416B (en) | Method for applying stable coating on silicone hydrogel contact lenses | |
CN106661224B (en) | Poly- (oxazoline -co- aziridine)-epichlorohydrin copolymer and application thereof | |
CN100411862C (en) | High optical quality molds for use in contact lens prodn. | |
CN103777254B (en) | The method for manufacturing soft silicone hydrogel contact lens | |
CA2777961C (en) | A silicone hydrogel lens with a covalently attached coating | |
JP4708023B2 (en) | Mold for contact lens manufacturing | |
TW201024083A (en) | Method for making silicone hydrogel contact lenses | |
CN106715101B (en) | Method for applying stable coating in silicone hydrogel contact lens on piece | |
HUE027812T2 (en) | Silicone hydrogel lenses with nano-textured surfaces | |
TW201942593A (en) | Contact lenses with a lubricious coating thereon | |
CN108367517A (en) | Method for producing the haptic lens with lubricated surface | |
JP7086924B2 (en) | Increased rigidity in soft contact lenses for astigmatism correction | |
TW200534982A (en) | Molds for producing contact lenses | |
CN100519124C (en) | Molds for producing contact lenses | |
AU2013203441B2 (en) | A silicone hydrogel lens with a crosslinked hydrophilic coating | |
AU2015201805A1 (en) | A silicone hydrogel lens with a crosslinked hydrophilic coating |